Compass Therapeutics (CMPX) FCF Margin (2024)
Compass Therapeutics (CMPX) has disclosed FCF Margin for 1 consecutive years, with 1265.18% as the latest value for Q2 2024.
- Quarterly FCF Margin changed N/A to 1265.18% in Q2 2024 from the year-ago period, while the trailing twelve-month figure was 5204.35% through Mar 2025, changed N/A year-over-year, with the annual reading at 5282.24% for FY2024, N/A changed from the prior year.
- FCF Margin hit 1265.18% in Q2 2024 for Compass Therapeutics.
- In the past five years, FCF Margin ranged from a high of 1265.18% in Q2 2024 to a low of 1265.18% in Q2 2024.